Tumor Fibroblast Growth Factor Receptor 4 Level Predicts the Efficacy of Lenvatinib in Patients With Advanced Hepatocellular Carcinoma

Biomarkers for optimizing the outcome of treatment with lenvatinib in patients with advanced hepatocellular carcinoma remain to be established despite intensive and comprehensive genomic research. Lenvatinib is characterized by its prominent inhibitory potency for fibroblast growth factor receptor (...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Transl Gastroenterol
Autori principali: Yamauchi, Masami, Ono, Atsushi, Ishikawa, Akira, Kodama, Kenichiro, Uchikawa, Shinsuke, Hatooka, Haruna, Zhang, Peiyi, Teraoka, Yuji, Morio, Kei, Fujino, Hatsue, Nakahara, Takashi, Murakami, Eisuke, Miki, Daiki, Kawaoka, Tomokazu, Tsuge, Masataka, Hiramatsu, Akira, Imamura, Michio, Hayes, Clair Nelson, Fujita, Masashi, Nakagawa, Hidewaki, Yasui, Wataru, Aikata, Hiroshi, Chayama, Kazuaki
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wolters Kluwer 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7263646/
https://ncbi.nlm.nih.gov/pubmed/32677805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/ctg.0000000000000179
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi